Literature DB >> 15153667

Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice.

Tamikazu Niwa1, Hisayasu Wada, Hazuki Ohashi, Naoki Iwamoto, Hirotoshi Ohta, Hirokazu Kirii, Hidehiko Fujii, Kuniaki Saito, Mitsuru Seishima.   

Abstract

BACKGROUND: We evaluated the role of IFN-gamma produced by bone marrow-derived cells in atherogenesis in LDLR(-/-) mice using bone marrow transplantation (BMT). METHODS AND
RESULTS: We generated IFN-gamma-deficient bone marrow transplanted LDLR(-/- )mice (IFN-gamma(-/-) BMT mice), and compared them with controls (IFN-gamma(+/+) BMT mice). These mice were fed a high-fat diet (HFD). Plasma total cholesterol and triglyceride levels did not differ between these two groups. After 6 weeks of HFD feeding, the atherosclerotic lesions of IFN-gamma(-/-) BMT mice were larger than those of IFN-gamma(+/+) BMT mice at the aortic sinus, aortic arch and abdominal aorta. After 12 weeks of HFD feeding, the significant differences between the two groups disappeared except for the atherosclerotic lesion in the aortic sinus. MOMA2, CD4, CD8 or alpha-smooth muscle actin-positive cells were detected in the atherosclerotic lesions. The cellular composition of the lesions was identical between the two groups, but the cellular density showed decreased concomitant with the increased extracellular matrix deposition in IFN-gamma(-/- )BMT mice.
CONCLUSIONS: These findings demonstrate that IFN-gamma produced by bone marrow-derived cells delays the progression of atherosclerosis without any effect on plasma lipids, and this suppression may be due to decreased extracellular matrix deposition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153667     DOI: 10.5551/jat.11.79

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  8 in total

Review 1.  The role of adaptive T cell immunity in atherosclerosis.

Authors:  Ziad Mallat; Soraya Taleb; Hafid Ait-Oufella; Alain Tedgui
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

2.  In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosis.

Authors:  Guoqiang Zhang; Amanda L Marshall; Alison L Thomas; Kelly A Kernan; Yanyuan Su; Renee C LeBoeuf; Xiu Rong Dong; B N Angela Tchao
Journal:  Atherosclerosis       Date:  2010-08-10       Impact factor: 5.162

3.  Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.

Authors:  Jing Wang; Sara Sjöberg; Viviane Tia; Blandine Secco; Han Chen; Min Yang; Galina K Sukhova; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-06-07       Impact factor: 5.162

Review 4.  Adipokines, adiposity, and atherosclerosis.

Authors:  Longhua Liu; Zunhan Shi; Xiaohui Ji; Wenqian Zhang; Jinwen Luan; Tarik Zahr; Li Qiang
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.261

Review 5.  The complex role of T-cell-based immunity in atherosclerosis.

Authors:  Pål Aukrust; Kari Otterdal; Arne Yndestad; Wiggo J Sandberg; Camilla Smith; Thor Ueland; Erik Øie; Jan K Damås; Lars Gullestad; Bente Halvorsen
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

Review 6.  Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.

Authors:  Dipak P Ramji; Thomas S Davies
Journal:  Cytokine Growth Factor Rev       Date:  2015-05-12       Impact factor: 7.638

Review 7.  T cell subsets and functions in atherosclerosis.

Authors:  Ryosuke Saigusa; Holger Winkels; Klaus Ley
Journal:  Nat Rev Cardiol       Date:  2020-03-16       Impact factor: 49.421

Review 8.  Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.

Authors:  Sarah S Burns; Reuben Kapur
Journal:  Stem Cell Reports       Date:  2020-07-30       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.